As shown in Figs. 4 and 5, the results of reporter assays, TF knockdown, and CRISPR/Cas9-mediated genome editing suggested that rs3862386 and rs10896081 might confer risk for BD by modulating PACS1 and YIF1A expression. This evidence concerns the gene PACS1 and Behcet disease.